Skip to Main Content

Paper Details

Recurrent arginine substitutions in the ACTG2 gene are the primary driver of disease burden and severity in visceral myopathy.
Hum Mutat
25
2020
ACTG2, ACTG2 gene, Arg63, CpG, Visceral myopathy, abnormal intestinal and bladder peristalsis, arginine, chronic intestinal pseudo-obstruction, dinucleotides, functional bladder, gastrointestinal obstruction, intestinal hypoperistalsis syndrome, megacystis, microcolon, missense alleles, p.Arg178, p.Arg257, p.Arg40, visceral myopathy
Author NameAffiliation
Zeynep Coban AkdemirBaylor College of Medicine
Margaret HarrCenter for Applied Genomics, Children's Hospital of Philadelphia
Anna C E HurstUniversity of Alabama at Birmingham
Shalini N JhangianiBaylor College of Medicine
Pengfei LiuBaylor College of Medicine
Jennifer E PoseyBaylor College of Medicine
James R LupskiBaylor College of Medicine
James R LupskiBaylor College of Medicine
James R LupskiBaylor College of Medicine
James R LupskiTexas Children's Hospital
James R LupskiBaylor College of Medicine
James R LupskiTexas Children's Hospital
James R LupskiBaylor College of Medicine
James R LupskiBaylor College of Medicine
Arthur L BeaudetBaylor College of Medicine
Arthur L BeaudetTexas Children's Hospital
Arthur L BeaudetBaylor College of Medicine
Michael F WanglerBaylor College of Medicine
Michael F WanglerTexas Children's Hospital
Michael F WanglerJan and Dan Duncan Neurological Research Institute, Texas Children's Hospital
Michael F WanglerBaylor College of Medicine
  • 1 - 21

Datasets